| pimecrolimus topical / Generic mfg. |
NCT00666159: Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis |
|
|
| Completed | 4 | 226 | US | tacrolimus ointment, Protopic, FK506 ointment, pimecrolimus cream, Elidel | Astellas Pharma Inc | Dermatitis, Atopic | 05/03 | 05/03 | | |
NCT00666302: A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis |
|
|
| Completed | 4 | 413 | US, Canada | tacrolimus ointment, Protopic, FK506 ointment, pimecrolimus cream, Elidel | Astellas Pharma Inc | Dermatitis, Atopic | 11/03 | 11/03 | | |
NCT00667160: Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis |
|
|
| Completed | 4 | 426 | US | tacrolimus ointment, Protopic, FK506 ointment, pimecrolimus cream, Elidel | Astellas Pharma Inc | Dermatitis, Atopic | 11/03 | 11/03 | | |
| Completed | 4 | 90 | US | Combination of pimecrolimus and fluticasone, Pimecrolimus cream, fluticasone, pimecrolimus | Children's Hospital of Philadelphia, Novartis Pharmaceuticals | Atopic Dermatitis | 06/05 | 06/05 | | |
NCT00925730: Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion |
|
|
| Completed | 4 | 20 | Europe | Pimecrolimus | Novartis | Atopic Dermatitis | 01/06 | | | |
NCT00510003 / 2004-001273-26: Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old |
|
|
| Completed | 4 | 117 | Europe | Pimecrolimus, Elidel | Novartis Pharmaceuticals | Atopic Dermatitis | 01/06 | | | |
NCT00509990 / 2017-001766-25: Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting |
|
|
| Completed | 4 | 200 | RoW | Pimecrolimus, Elidel | Novartis Pharmaceuticals | Atopic Dermatitis | 09/07 | | | |
| Completed | 4 | 41 | Europe | Pimecrolimus cream 1%, ASM981 | Novartis | Atopic Dermatitis | 12/07 | 12/07 | | |
| Terminated | 4 | 1091 | US | Pimecrolimus, Elidel, Corticosteroid | Novartis Pharmaceuticals | Atopic Dermatitis | 01/08 | 11/08 | | |
| Completed | 4 | 80 | Europe | Zarzenda, Elidel | Bayer | Mild to Moderate Atopic Dermatitis | 09/08 | 09/08 | | |
NCT01177566: Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis. |
|
|
| Completed | 4 | 20 | US | pimecrolimus, topical medical device | Emer, Jason, M.D., Ferndale Laboratories | Atopic Dermatitis | 03/10 | 03/10 | | |
NCT01202149: Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis |
|
|
| Completed | 4 | 30 | US | Elidel (pimecrolimus cream, 1%) Hylatopic Plus Emollient Foam (non-medicated device) | Frankel, Amylynne, M.D., Onset Therapeutics, Inc | Eczema, Atopic Dermatitis | 11/10 | 11/10 | | |
